2-Methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells

72Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

2-Methoxyestradiol (2ME) is an endogenous metabolite with estrogen receptor-independent anti-tumor activity. The current study seeks to determine the mechanism of anti-tumor activity of 2ME on human chondrosarcoma. 2ME caused a time- and dose-dependent cytotoxity in chondrosarcoma cells, while primary chondrocytes were minimally affected. Cells accumulated in G0/G1 phase in response to 2ME and DAPI stain indicated an induction of apoptosis. Bax, Cytochrome C, and Caspase-3 protein expression were increased, while p53 expression was decreased. A higher Bax/Bcl-2 ratio followed 2ME treatment. 2ME has a potentially promising role as a systemic therapy of chondrosarcoma when the mechanism of action is better delineated. © 2007 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Cite

CITATION STYLE

APA

Fong, Y. C., Yang, W. H., Hsu, S. F., Hsu, H. C., Tseng, K. F., Hsu, C. J., … Scully, S. P. (2007). 2-Methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells. Journal of Orthopaedic Research, 25(8), 1106–1114. https://doi.org/10.1002/jor.20364

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free